Intense Monitoring Study on Tyvyt

Clinical trial NCT04237233 · UNKNOWN

Trial details

NCT number: NCT04237233
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Relapsed or Refractory Classical Hodgkin's Lymphoma

Start date: 2020-04-02
Primary completion: 2023-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.